Correlation Between Chorokbaem Healthcare and INtRON Biotechnology
Can any of the company-specific risk be diversified away by investing in both Chorokbaem Healthcare and INtRON Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Chorokbaem Healthcare and INtRON Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Chorokbaem Healthcare Co and iNtRON Biotechnology, you can compare the effects of market volatilities on Chorokbaem Healthcare and INtRON Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Chorokbaem Healthcare with a short position of INtRON Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Chorokbaem Healthcare and INtRON Biotechnology.
Diversification Opportunities for Chorokbaem Healthcare and INtRON Biotechnology
0.7 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Chorokbaem and INtRON is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Chorokbaem Healthcare Co and iNtRON Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on iNtRON Biotechnology and Chorokbaem Healthcare is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Chorokbaem Healthcare Co are associated (or correlated) with INtRON Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of iNtRON Biotechnology has no effect on the direction of Chorokbaem Healthcare i.e., Chorokbaem Healthcare and INtRON Biotechnology go up and down completely randomly.
Pair Corralation between Chorokbaem Healthcare and INtRON Biotechnology
Assuming the 90 days trading horizon Chorokbaem Healthcare Co is expected to under-perform the INtRON Biotechnology. But the stock apears to be less risky and, when comparing its historical volatility, Chorokbaem Healthcare Co is 1.21 times less risky than INtRON Biotechnology. The stock trades about -0.03 of its potential returns per unit of risk. The iNtRON Biotechnology is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 808,000 in iNtRON Biotechnology on August 31, 2024 and sell it today you would lose (253,000) from holding iNtRON Biotechnology or give up 31.31% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 99.78% |
| Values | Daily Returns |
Chorokbaem Healthcare Co vs. iNtRON Biotechnology
Performance |
| Timeline |
| Chorokbaem Healthcare |
| iNtRON Biotechnology |
Chorokbaem Healthcare and INtRON Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Chorokbaem Healthcare and INtRON Biotechnology
The main advantage of trading using opposite Chorokbaem Healthcare and INtRON Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Chorokbaem Healthcare position performs unexpectedly, INtRON Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in INtRON Biotechnology will offset losses from the drop in INtRON Biotechnology's long position.| Chorokbaem Healthcare vs. AptaBio Therapeutics | Chorokbaem Healthcare vs. KT Hitel | Chorokbaem Healthcare vs. SillaJen | Chorokbaem Healthcare vs. Cytogen |
| INtRON Biotechnology vs. AptaBio Therapeutics | INtRON Biotechnology vs. KT Hitel | INtRON Biotechnology vs. SillaJen | INtRON Biotechnology vs. Cytogen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |